Item 2.02. Results of Operations and Financial Condition.
On July 30, 2009, Mylan Inc., a Pennsylvania corporation, issued a press
release reporting its financial results for the period ended June 30, 2009. A
copy of the press release is attached hereto as Exhibit 99.1.
The information in this report (including the exhibit) shall not be deemed to
be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or otherwise subject to the liability of that
section, and shall not be incorporated by reference into any registration
statement or other document filed under the Securities Act of 1933, as amended,
or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
(c) On July 29, 2009, Mylan Inc. ("Mylan" or the "Company") announced that
Chief Operating Officer Heather Bresch has been named President of the Company,
and that Head of Global Technical Operations Rajiv Malik, has been named Mylan's
Chief Operating Officer, in each case effective immediately.
Ms. Bresch, 40, had served as Mylan's Executive Vice President and Chief
Operating Officer since October 2007, before which she was Head of North
American Operations since January 2007. She previously served as Senior Vice
President, Strategic Corporate Development, beginning in February 2006.
Ms. Bresch joined Mylan in 1992, and has held a number of management positions
during her tenure, including Vice President, Strategic Corporate Development
from May 2005 to February 2006, Vice President of Public and Government
Relations from February 2004 to April 2005, Director of Government Relations
from March 2002 to February 2004, and Director of Business Development from
January 2001 to March 2002.
Mr. Malik, 48, had served as Mylan's Head of Global Technical Operations
since January 2007, and as Executive Vice President since October 2007.
Previously, he served as Chief Executive Officer of Matrix Laboratories from
July 2005 to June 2008. Prior to joining Matrix, he served as Head of Global
Development and Registrations for Sandoz GmbH from September 2003 to July 2005.
Prior to joining Sandoz, Mr. Malik was Head of Global Regulatory Affairs and
Head of Pharma Research for Ranbaxy from October 1999 to September 2003.
Both Ms. Bresch and Mr. Malik are party to an Executive Employment Agreement
and a Transition and Succession Agreement, which are described in the Company's
2009 annual proxy statement and will continue in effect in accordance with their
current terms and conditions.
A copy of the press release issued by the Company regarding Ms. Bresch's and
Mr. Malik's promotions is attached as Exhibit 99.2.
Add
MYL to Portfolio
Set Alert
Email to a
Friend